Literature DB >> 15381948

[State of cancer in Spain: incidence].

G López-Abente1, M Pollán, N Aragonés, B Pérez Gómez, V Hernández Barrera, V Lope, B Suárez.   

Abstract

It is estimated that at present in Spain around 162,000 cases of cancer are diagnosed each year (without including non-melanoma skin cancer), of which 25,600 correspond to colorectal carcinomas, which is the most frequent of all tumours in absolute terms. The next tumour in terms of frequency is lung cancer with 18,800 new cases, followed by breast cancer in women with 15,979 cases. When the incidence of cancer is compared with that in neighbouring countries, Spain shows adjusted rates in men higher than those of the average for the EU, occupying the 5th place. However, in women, Spain shows the lowest rates together with Greece. Spain occupies the first place for cancer of the bladder in men, with rates that are considerably higher than those of the rest of the countries. It is important to verify the increase underway in the incidence of cancer in Spain and the contrast that this represents facing the evolution of mortality. For many important tumoral localisations (lung, stomach, bladder), the population registers do not cover the provinces where there is a greater mortality.

Entities:  

Mesh:

Year:  2004        PMID: 15381948     DOI: 10.4321/s1137-66272004000300001

Source DB:  PubMed          Journal:  An Sist Sanit Navar        ISSN: 1137-6627            Impact factor:   0.829


  10 in total

1.  Complex organochlorine pesticide mixtures as determinant factor for breast cancer risk: a population-based case-control study in the Canary Islands (Spain).

Authors:  Luis D Boada; Manuel Zumbado; Luis Alberto Henríquez-Hernández; Maira Almeida-González; Eva E Alvarez-León; Lluis Serra-Majem; Octavio P Luzardo
Journal:  Environ Health       Date:  2012-04-25       Impact factor: 5.984

2.  Colorectal cancer prevention.

Authors:  M Andreu; M Marzo; J Mascort; E Quintero; P García-Alfonso; C López-Ibor; T Castells; P Pérez Segura
Journal:  Clin Transl Oncol       Date:  2009-02       Impact factor: 3.405

3.  [Prevention of colorectal cancer].

Authors:  Montserrat Andreu García; Mercè Marzo; Juanjo Mascort; Enrique Quintero; Pilar García-Alfonso; Cristina López-Ibor; Antoni Castells; Pedro Pérez Segura
Journal:  Aten Primaria       Date:  2009-03-21       Impact factor: 1.137

4.  Cancer incidence in Spain, 2015.

Authors:  J Galceran; A Ameijide; M Carulla; A Mateos; J R Quirós; D Rojas; A Alemán; A Torrella; M Chico; M Vicente; J M Díaz; N Larrañaga; R Marcos-Gragera; M J Sánchez; J Perucha; P Franch; C Navarro; E Ardanaz; J Bigorra; P Rodrigo; R Peris Bonet
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

5.  Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain.

Authors:  E Calvo Aller; P Maroto; N Kreif; J L González Larriba; M López-Brea; D Castellano; B Martí; S Díaz Cerezo
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

Review 6.  The Fanconi anaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets.

Authors:  Maria José García; Javier Benítez
Journal:  Clin Transl Oncol       Date:  2008-02       Impact factor: 3.405

7.  [Epidemiological Evolution of Lung Cancer in the South of Spain from 1990 to 2010].

Authors:  Alberto Caballero Vázquez; Ana Dolores Romero Ortiz; Jose Manuel González de Vega San Román; Raimundo García Del Moral; Bernardino Alcázar Navarrete
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-01-20

8.  Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group.

Authors:  Mariano Provencio; Josefa Terrasa; Pilar Garrido; Rosario García Campelo; Francisco Aparisi; Pilar Diz; David Aguiar; Carlos García-Giron; Julia Hidalgo; Carlos Aguado; Jorge García González; Emilio Esteban; Lorenzo Gómez-Aldavarí; Teresa Moran; Oscar Juan; Luís Enrique Chara; Juan L Marti; Rafael López Castro; Ana Laura Ortega; Elia Martínez Moreno; Juan Coves; Ana M Sánchez Peña; Joaquim Bosch-Barrera; Amparo Sánchez Gastaldo; Natalia Fernández Núñez; Edel Del Barco; Manuel Cobo; Dolores Isla; Margarita Majem; Fátima Navarro; Virginia Calvo
Journal:  BMC Cancer       Date:  2021-03-06       Impact factor: 4.430

9.  Cancer incidence estimation from mortality data: a validation study within a population-based cancer registry.

Authors:  Daniel Redondo-Sánchez; Miguel Rodríguez-Barranco; Alberto Ameijide; Francisco Javier Alonso; Pablo Fernández-Navarro; Jose Juan Jiménez-Moleón; María-José Sánchez
Journal:  Popul Health Metr       Date:  2021-03-23

10.  The hospital burden of disease associated with bone metastases and skeletal-related events in patients with breast cancer, lung cancer, or prostate cancer in Spain.

Authors:  R D Pockett; D Castellano; P McEwan; A Oglesby; B L Barber; K Chung
Journal:  Eur J Cancer Care (Engl)       Date:  2010-11       Impact factor: 2.520

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.